Resumen de Investigación
Analyzed using Evidence Intelligence™

i3 CGM shows reliable performance for diabetes management

Última actualización 12 de julio de 2026

Key finding

MARD for abdomen sensors was 9.4%.

This study evaluated the True Vie I3 Continuous Glucose Monitoring System in adults with diabetes, finding high agreement rates and minimal pain during sensor use.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the True Vie I3 Continuous Glucose Monitoring System in adults with diabetes, finding high agreement rates and minimal pain during sensor use.

Clinical relevance

These findings are significant as they suggest that the True Vie I3 Continuous Glucose Monitoring System can provide reliable glucose monitoring for adults with diabetes, which is crucial for effective diabetes management. High accuracy and minimal discomfort can enhance patient adherence to monitoring, ultimately improving glycemic control and reducing complications associated with diabetes.

Keep in mind

The study did not provide a detailed description of the participant demographics. Sample size and generalizability to broader populations were not specified. Effectiveness claims were marked as unclear for several outcomes.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Nina J, Manuela L, Sükrü &, et al. Evaluation of the True Vie I3 Continuous Glucose Monitoring System in Adults with Diabetes. Diabetes Therapy. 2025;17(2):287-299. doi:10.1007/s13300-025-01832-6

Efectos Principales

MARD for abdomen sensors was 9.4%, indicating low error in glucose readings.

Agreement rates for abdomen sensors reached 95.5%, showing high accuracy.

Sensor attachment rate for abdomen sensors was 100%, demonstrating excellent usability.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous glucose monitoring and Agreement Rates for Arm Sensors, Agreement rates for abdomen sensors, Mean Absolute Relative Difference (MARD) for Abdomen Sensors, and 5 more.

Primary intervention

Continuous glucose monitoring

Primary outcomes

  • Agreement Rates for Arm Sensors
  • Agreement rates for abdomen sensors
  • Mean Absolute Relative Difference (MARD) for Abdomen Sensors

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

8
Evidence pairs
8
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 55

1

Related topics

8

Evidence pairs

127

Related studies

Why it is useful

  • Contributes to 8 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Tema de evidencia

Diabetes Technology

matched_intervention

Core evidence

Study findings

The primary outcomes reported in this study.

Agreement rates for abdomen sensors

Continuous glucose monitoring → Agreement rates for abdomen sensors

Continuous glucose monitoring → Agreement rates for abdomen sensors

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Agreement Rates for Arm Sensors

Continuous glucose monitoring → Agreement Rates for Arm Sensors

Continuous glucose monitoring → Agreement Rates for Arm Sensors

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Mean Absolute Relative Difference (MARD) for Abdomen Sensors

Continuous glucose monitoring → Mean Absolute Relative Difference (MARD) for Abdomen Sensors

Continuous glucose monitoring → Mean Absolute Relative Difference (MARD) for Abdomen Sensors

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Mean Absolute Relative Difference (MARD) for Arm Sensors

Continuous glucose monitoring → Mean Absolute Relative Difference (MARD) for Arm Sensors

Continuous glucose monitoring → Mean Absolute Relative Difference (MARD) for Arm Sensors

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Pain during insertion

Continuous glucose monitoring → Pain during insertion

Continuous glucose monitoring → Pain during insertion

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Pain during removal

Continuous glucose monitoring → Pain during removal

Continuous glucose monitoring → Pain during removal

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Safety events

Continuous glucose monitoring → Safety events

Continuous glucose monitoring → Safety events

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Sensor attachment rate for arm sensors

Continuous glucose monitoring → Sensor attachment rate for arm sensors

Continuous glucose monitoring → Sensor attachment rate for arm sensors

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • MARD for arm sensors was 9.8%, indicating reliable performance.
  • Pain during insertion and removal was reported as minimal.
  • No unexpected safety issues were identified during the study.
who this applies

A quién se aplica

  • Adults diagnosed with diabetes.
  • Individuals seeking continuous glucose monitoring solutions.
keep in mind

Tener en Cuenta

  • Findings may not be applicable to all diabetes types or age groups.
  • Further studies are needed to confirm long-term effectiveness.
  • The study's sample size and participant characteristics were not detailed.
between the lines

Entre Líneas

  • The study did not provide a detailed description of the participant demographics.
  • Sample size and generalizability to broader populations were not specified.
  • Effectiveness claims were marked as unclear for several outcomes.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Delivery Systems and Agreement rates for abdomen sensors, Insulin Delivery Systems and Agreement Rates for Arm Sensors.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Continuous glucose monitoring improve agreement rates for arm sensors?

Emerging Evidence

Continuous glucose monitoring appears to improve Agreement Rates for Arm Sensors.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Agreement Rates for Arm Sensors

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Continuous glucose monitoring improve agreement rates for abdomen sensors?

Emerging Evidence

Continuous glucose monitoring appears to improve Agreement rates for abdomen sensors.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Agreement rates for abdomen sensors

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Continuous glucose monitoring improve mean absolute relative difference (mard) for abdomen sensors?

Emerging Evidence

Continuous glucose monitoring appears to improve Mean Absolute Relative Difference (MARD) for Abdomen Sensors.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Mean Absolute Relative Difference (MARD) for Abdomen Sensors

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Continuous glucose monitoring improve mean absolute relative difference (mard) for arm sensors?

Emerging Evidence

Continuous glucose monitoring appears to improve Mean Absolute Relative Difference (MARD) for Arm Sensors.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Mean Absolute Relative Difference (MARD) for Arm Sensors

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.